Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck
- 2 July 2001
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 23 (8) , 629-636
- https://doi.org/10.1002/hed.1089
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomasHuman Pathology, 1999
- Site‐specific Localization of Epstein‐Barr Virus in Pharyngeal CarcinomasJapanese Journal of Cancer Research, 1998
- Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinomaHuman Pathology, 1998
- Lymphoepithelial carcinoma of the larynx and hypopharynx: Study of eight cases with relationship to Epstein-Barr virus and p53 gene alterations, and review of the literatureHuman Pathology, 1996
- Basaloid-squamous carcinoma of the nasopharynx. An epstein–barr virus–associated neoplasm compared with morphologically identical tumors occurring in other sitesCancer, 1995
- Assessment of p53 expression in nasopharyngeal carcinoma*1Human Pathology, 1995
- P53 overexpression and Epstein‐Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomasThe Journal of Pathology, 1993
- p53, guardian of the genomeNature, 1992
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: Antibodies to EBV associated Membrane and Viral Capsid Antigens in Burkitt Lymphoma PatientsNature, 1970
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964